search icon
smmt-img

Summit Therapeutics PLC Share Price

SMMT
NMQ
$16.14
-$0.9
(-5.28%)
1D
Industry: Biotechnology Sector: Health Care

Summit Therapeutics PLC Analyst Forecast

Summit Therapeutics PLC Share Price Chart

Summit Therapeutics PLC Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.69B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.26M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.51
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$15.55 L
$36.91 H
$16.14

About Summit Therapeutics PLC, Common Stock

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida. more

Industry: BiotechnologySector: Health Care

Summit Therapeutics PLC Stock Returns

Time FrameSMMTSectorS&P500
1-Week Return-13.41%-1%-0.35%
1-Month Return-1.1%1.08%1.9%
3-Month Return-22.44%9.43%4.73%
6-Month Return-39.72%16.01%10.87%
1-Year Return-6.32%10.35%16.88%
3-Year Return271.24%15.52%73.95%
5-Year Return226.44%32.15%82.73%
10-Year Return85.22%132.93%269.09%

Summit Therapeutics PLC Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue860.00K1.81M704.29K--[{"date":"2020-12-31","value":47.54,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":38.93,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue--2.51M2.05M15.01M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":16.75,"profit":true},{"date":"2023-12-31","value":13.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit860.00K1.81M(1.81M)(2.05M)(15.01M)[{"date":"2020-12-31","value":47.54,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-100.06,"profit":false},{"date":"2023-12-31","value":-113.32,"profit":false},{"date":"2024-12-31","value":-829.57,"profit":false}]
Gross Margin100.00%100.00%(256.99%)--[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-256.99,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses53.19M88.00M64.28M87.69M211.30M[{"date":"2020-12-31","value":25.17,"profit":true},{"date":"2021-12-31","value":41.64,"profit":true},{"date":"2022-12-31","value":30.42,"profit":true},{"date":"2023-12-31","value":41.5,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(53.19M)(86.19M)(59.63M)(89.74M)313.00K[{"date":"2020-12-31","value":-16994.57,"profit":false},{"date":"2021-12-31","value":-27535.46,"profit":false},{"date":"2022-12-31","value":-19052.08,"profit":false},{"date":"2023-12-31","value":-28669.65,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(44.06K)(2.70M)(11.09M)(532.20M)(216.85M)[{"date":"2020-12-31","value":-4405700,"profit":false},{"date":"2021-12-31","value":-269700000,"profit":false},{"date":"2022-12-31","value":-1109400000,"profit":false},{"date":"2023-12-31","value":-53219600000,"profit":false},{"date":"2024-12-31","value":-21684800000,"profit":false}]
Pre-Tax Income(52.91M)(88.60M)(78.78M)(615.87M)(221.31M)[{"date":"2020-12-31","value":-5291000000,"profit":false},{"date":"2021-12-31","value":-8860200000,"profit":false},{"date":"2022-12-31","value":-7878200000,"profit":false},{"date":"2023-12-31","value":-61587400000,"profit":false},{"date":"2024-12-31","value":-22131500000,"profit":false}]
Income Taxes(213.00K)(2.46M)(4.40M)(946.00K)(313.00K)[{"date":"2020-12-31","value":-21300000,"profit":false},{"date":"2021-12-31","value":-245500000,"profit":false},{"date":"2022-12-31","value":-440100000,"profit":false},{"date":"2023-12-31","value":-94600000,"profit":false},{"date":"2024-12-31","value":-31300000,"profit":false}]
Income After Taxes(52.70M)(86.15M)(74.38M)(614.93M)(221.00M)[{"date":"2020-12-31","value":-5269700000,"profit":false},{"date":"2021-12-31","value":-8614700000,"profit":false},{"date":"2022-12-31","value":-7438100000,"profit":false},{"date":"2023-12-31","value":-61492800000,"profit":false},{"date":"2024-12-31","value":-22100200000,"profit":false}]
Income From Continuous Operations(52.70M)(88.60M)(78.78M)(614.93M)(221.29M)[{"date":"2020-12-31","value":-5269700000,"profit":false},{"date":"2021-12-31","value":-8860200000,"profit":false},{"date":"2022-12-31","value":-7878200000,"profit":false},{"date":"2023-12-31","value":-61492800000,"profit":false},{"date":"2024-12-31","value":-22128800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(52.70M)(86.15M)(78.78M)(614.93M)(221.31M)[{"date":"2020-12-31","value":-5269700000,"profit":false},{"date":"2021-12-31","value":-8614700000,"profit":false},{"date":"2022-12-31","value":-7878200000,"profit":false},{"date":"2023-12-31","value":-61492800000,"profit":false},{"date":"2024-12-31","value":-22131500000,"profit":false}]
EPS (Diluted)(3.73)(3.68)(0.60)(1.52)(0.30)[{"date":"2020-12-31","value":-372.88,"profit":false},{"date":"2021-12-31","value":-368,"profit":false},{"date":"2022-12-31","value":-60,"profit":false},{"date":"2023-12-31","value":-152,"profit":false},{"date":"2024-12-31","value":-30,"profit":false}]

Summit Therapeutics PLC Ratios

Summit Therapeutics PLC Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SMMT
Current Ratio 3.80

Summit Therapeutics PLC Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SMMT
ROA (LTM) -152.88%
ROE (LTM) -292.49%

Summit Therapeutics PLC Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SMMT
Debt Ratio Lower is generally better. Negative is bad. 0.27
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.73

Summit Therapeutics PLC Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SMMT
Trailing PE NM
Forward PE NM
P/S (TTM) 753.90
P/B 65.98
Price/FCF NM
EV/R 6425.28
EV/Ebitda NM
PEG NM

FAQs

What is Summit Therapeutics PLC share price today?

Summit Therapeutics PLC (SMMT) share price today is $16.14

Can Indians buy Summit Therapeutics PLC shares?

Yes, Indians can buy shares of Summit Therapeutics PLC (SMMT) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SMMT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Summit Therapeutics PLC be purchased?

Yes, you can purchase fractional shares of Summit Therapeutics PLC (SMMT) via the Vested app. You can start investing in Summit Therapeutics PLC (SMMT) with a minimum investment of $1.

How to invest in Summit Therapeutics PLC shares from India?

You can invest in shares of Summit Therapeutics PLC (SMMT) via Vested in three simple steps:

  • Click on Sign Up or Invest in SMMT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Summit Therapeutics PLC shares
What is Summit Therapeutics PLC 52-week high and low stock price?

The 52-week high price of Summit Therapeutics PLC (SMMT) is $36.91. The 52-week low price of Summit Therapeutics PLC (SMMT) is $15.55.

What is Summit Therapeutics PLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Summit Therapeutics PLC (SMMT) is

What is Summit Therapeutics PLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Summit Therapeutics PLC (SMMT) is 65.98

What is Summit Therapeutics PLC dividend yield?

The dividend yield of Summit Therapeutics PLC (SMMT) is 0.00%

What is the Market Cap of Summit Therapeutics PLC?

The market capitalization of Summit Therapeutics PLC (SMMT) is $12.69B

What is Summit Therapeutics PLC's stock symbol?

The stock symbol (or ticker) of Summit Therapeutics PLC is SMMT

How Can Investors Use Summit Therapeutics PLC Share Price Data for Long-Term Investment Decisions?

Consider the share price of Summit Therapeutics PLC as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Summit Therapeutics PLC has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Summit Therapeutics PLC shares for Indian investors?

When investing in Summit Therapeutics PLC shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Summit Therapeutics PLC stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Summit Therapeutics PLC share price with other stocks in the same sector?

Rather than merely checking the share price of Summit Therapeutics PLC and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Summit Therapeutics PLC stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top